© 2024 KOSU
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

A clinical trial of a drug treating Alzheimer's was successful. What does that mean for patients?

Published October 5, 2022 at 12:52 PM CDT
A woman, suffering from Alzheimer's desease, holds the hand of a relative on March 18, 2011 in a retirement house in Angervilliers, eastern France. (Sebastien Bozon/AFP via Getty Images)
A woman, suffering from Alzheimer's desease, holds the hand of a relative on March 18, 2011 in a retirement house in Angervilliers, eastern France. (Sebastien Bozon/AFP via Getty Images)

Here & Now‘s Scott Tong speaks with STAT’s biotech reporter Damian Garde about a promising study of a drug that could reduce the cognitive effects of Alzheimer’s disease.

This article was originally published on WBUR.org.

Copyright 2022 NPR. To see more, visit https://www.npr.org.

Tags
Health Alzheimer's Disease
You make KOSU possible.
KOSU is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.
Donate Now
Related Content